These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 26075792)
1. An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes. Mohankumar KM; Currle DS; White E; Boulos N; Dapper J; Eden C; Nimmervoll B; Thiruvenkatam R; Connelly M; Kranenburg TA; Neale G; Olsen S; Wang YD; Finkelstein D; Wright K; Gupta K; Ellison DW; Thomas AO; Gilbertson RJ Nat Genet; 2015 Aug; 47(8):878-87. PubMed ID: 26075792 [TBL] [Abstract][Full Text] [Related]
2. Integrative genomics identified RFC3 as an amplified candidate oncogene in esophageal adenocarcinoma. Lockwood WW; Thu KL; Lin L; Pikor LA; Chari R; Lam WL; Beer DG Clin Cancer Res; 2012 Apr; 18(7):1936-46. PubMed ID: 22328562 [TBL] [Abstract][Full Text] [Related]
3. Epigenetic genome-wide analysis identifies BEX1 as a candidate tumour suppressor gene in paediatric intracranial ependymoma. Karakoula K; Jacques TS; Phipps KP; Harkness W; Thompson D; Harding BN; Darling JL; Warr TJ Cancer Lett; 2014 Apr; 346(1):34-44. PubMed ID: 24333734 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Mack SC; Pajtler KW; Chavez L; Okonechnikov K; Bertrand KC; Wang X; Erkek S; Federation A; Song A; Lee C; Wang X; McDonald L; Morrow JJ; Saiakhova A; Sin-Chan P; Wu Q; Michaelraj KA; Miller TE; Hubert CG; Ryzhova M; Garzia L; Donovan L; Dombrowski S; Factor DC; Luu B; Valentim CLL; Gimple RC; Morton A; Kim L; Prager BC; Lee JJY; Wu X; Zuccaro J; Thompson Y; Holgado BL; Reimand J; Ke SQ; Tropper A; Lai S; Vijayarajah S; Doan S; Mahadev V; Miñan AF; Gröbner SN; Lienhard M; Zapatka M; Huang Z; Aldape KD; Carcaboso AM; Houghton PJ; Keir ST; Milde T; Witt H; Li Y; Li CJ; Bian XW; Jones DTW; Scott I; Singh SK; Huang A; Dirks PB; Bouffet E; Bradner JE; Ramaswamy V; Jabado N; Rutka JT; Northcott PA; Lupien M; Lichter P; Korshunov A; Scacheri PC; Pfister SM; Kool M; Taylor MD; Rich JN Nature; 2018 Jan; 553(7686):101-105. PubMed ID: 29258295 [TBL] [Abstract][Full Text] [Related]
5. Oncogenes without a Neighboring Tumor-Suppressor Gene Are More Prone to Amplification. Wu WK; Li X; Wang X; Dai RZ; Cheng AS; Wang MH; Kwong T; Chow TC; Yu J; Chan MT; Wong SH Mol Biol Evol; 2017 Apr; 34(4):903-907. PubMed ID: 28087780 [TBL] [Abstract][Full Text] [Related]
6. Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death. Rogers HA; Kilday JP; Mayne C; Ward J; Adamowicz-Brice M; Schwalbe EC; Clifford SC; Coyle B; Grundy RG Acta Neuropathol; 2012 May; 123(5):711-25. PubMed ID: 22109108 [TBL] [Abstract][Full Text] [Related]
7. Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas. Lassmann S; Weis R; Makowiec F; Roth J; Danciu M; Hopt U; Werner M J Mol Med (Berl); 2007 Mar; 85(3):293-304. PubMed ID: 17143621 [TBL] [Abstract][Full Text] [Related]
8. Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma. Both J; Krijgsman O; Bras J; Schaap GR; Baas F; Ylstra B; Hulsebos TJ PLoS One; 2014; 9(12):e115835. PubMed ID: 25551557 [TBL] [Abstract][Full Text] [Related]
9. Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling. Cornen S; Guille A; Adélaïde J; Addou-Klouche L; Finetti P; Saade MR; Manai M; Carbuccia N; Bekhouche I; Letessier A; Raynaud S; Charafe-Jauffret E; Jacquemier J; Spicuglia S; de The H; Viens P; Bertucci F; Birnbaum D; Chaffanet M PLoS One; 2014; 9(1):e81843. PubMed ID: 24416132 [TBL] [Abstract][Full Text] [Related]
10. Pitfalls in experimental designs for characterizing the transcriptional, methylational and copy number changes of oncogenes and tumor suppressor genes. Zhang Y; Xia J; Zhang Y; Qin Y; Yang D; Qi L; Zhao W; Wang C; Guo Z PLoS One; 2013; 8(3):e58163. PubMed ID: 23472150 [TBL] [Abstract][Full Text] [Related]
11. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics. Modena P; Lualdi E; Facchinetti F; Veltman J; Reid JF; Minardi S; Janssen I; Giangaspero F; Forni M; Finocchiaro G; Genitori L; Giordano F; Riccardi R; Schoenmakers EF; Massimino M; Sozzi G J Clin Oncol; 2006 Nov; 24(33):5223-33. PubMed ID: 17114655 [TBL] [Abstract][Full Text] [Related]
12. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Mendrzyk F; Korshunov A; Benner A; Toedt G; Pfister S; Radlwimmer B; Lichter P Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2070-9. PubMed ID: 16609018 [TBL] [Abstract][Full Text] [Related]
13. Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer. Fan B; Dachrut S; Coral H; Yuen ST; Chu KM; Law S; Zhang L; Ji J; Leung SY; Chen X PLoS One; 2012; 7(4):e29824. PubMed ID: 22539939 [TBL] [Abstract][Full Text] [Related]
14. Metastasizing anaplastic ependymoma in an adult. Chromosomal imbalances, metabolic and gene expression profiles. Lopez-Gines C; Gil-Benso R; Faus C; Monleon D; Mata M; Morales JM; Cigudosa JC; Gonzalez-Darder J; Celda B; Cerda-Nicolas M Histopathology; 2009 Mar; 54(4):500-4. PubMed ID: 19309408 [No Abstract] [Full Text] [Related]
16. Distinct and competitive regulatory patterns of tumor suppressor genes and oncogenes in ovarian cancer. Zhao M; Sun J; Zhao Z PLoS One; 2012; 7(8):e44175. PubMed ID: 22952919 [TBL] [Abstract][Full Text] [Related]